Skip to main content
Premium Trial:

Request an Annual Quote

ChondroGene Completes GeneNews Acquisition

NEW YORK, Dec. 1 (GenomeWeb News) - ChondroGene said today that it has completed its acquisition of GeneNews.


Under the deal, ChondroGene acquires all outstanding shares of GeneNews in exchange for 4 million shares of its own stock at a price of $0.50 per share.


According to Toronto-based ChondroGene, GeneNews' principal asset is undisclosed intellectual property related to pharmacogenomics and personalized medicine. ChondroGene, which was co-founded by GeneNews founder Choong-Chin Liew, previously held licensing rights to the technology in the fields of osteoarthritis, rheumatoid arthritis, and traumatic joint injury.



The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.